Showing results (2361-2370 of 2,672) with videos related to

Sort By:
Pageof 268
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 2, 2025
A pilot study to determine the feasibility and safety of pharmacist and nurse driven management of venetoclax ramp-up in patients with chronic lymphocytic leukemiaRachel J Bailen, Monica I Aasum, Linda M Tamminga, et al.
Nature Communications|January 29, 2024
Highly loaded bimetallic iron-cobalt catalysts for hydrogen release from ammoniaShilong Chen, Jelena Jelic, Denise Rein, et al.
Cancer Research|May 20, 2016
Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and InvasionSebastian Marwitz, Sofia Depner, Dmytro Dvornikov, et al.
Allergy|January 31, 2025
Dichotomous STAT5 and STAT6 Activation in T Cells Reflects Cytokine Shifts Between Blood and Skin in Atopic DermatitisAndreas Boldt, Regina Treudler, Marie Rabe, et al.
The European Respiratory Journal|December 14, 2022
Development of a tool to detect small airways dysfunction in asthma clinical practiceJanwillem Kocks, Thys van der Molen, Jaco Voorham, et al.
Blood|April 15, 2018
TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphomaAlexander Jethwa, Mikołaj Słabicki, Jennifer Hüllein, et al.
Schriftenreihe Des Vereins Fur Wasser-, Boden- Und Lufthygiene|May 10, 2000
[Detection of airborne cultivatable microorganisms from compost sites--emissions and imissions]R Hofmann, E M Beck, R Böhm, et al.
Journal of Alzheimer'S Disease : JAD|June 12, 2018
Mediterranean Diet, Its Components, and Amyloid Imaging BiomarkersMaria Vassilaki, Jeremiah A Aakre, Jeremy A Syrjanen, et al.
Journal of Medical Genetics|August 31, 2016
FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrumMiriam S Reuter, Angelika Riess, Ute Moog, et al.
Advances in Therapy|May 5, 2018
Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe AsthmaWilliam W Busse, Jorge F Maspero, Klaus F Rabe, et al.
Pageof 268